BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
6.03
+0.02 (0.33%)
At close: Aug 1, 2025, 4:00 PM
6.10
+0.07 (1.16%)
After-hours: Aug 1, 2025, 7:23 PM EDT

Exscientia Statistics

Total Valuation

BioVie has a market cap or net worth of $11.18 million. The enterprise value is -$11.60 million.

Market Cap11.18M
Enterprise Value -11.60M

Important Dates

The next estimated earnings date is Monday, September 29, 2025, after market close.

Earnings Date Sep 29, 2025
Ex-Dividend Date n/a

Share Statistics

BioVie has 1.85 million shares outstanding. The number of shares has increased by 199.08% in one year.

Current Share Class 1.85M
Shares Outstanding 1.85M
Shares Change (YoY) +199.08%
Shares Change (QoQ) +17.75%
Owned by Insiders (%) 1.31%
Owned by Institutions (%) 5.84%
Float 1.83M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.51
P/TBV Ratio 0.53
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.32, with a Debt / Equity ratio of 0.02.

Current Ratio 9.32
Quick Ratio 9.09
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -25.00

Financial Efficiency

Return on equity (ROE) is -93.23% and return on invested capital (ROIC) is -48.44%.

Return on Equity (ROE) -93.23%
Return on Assets (ROA) -42.51%
Return on Invested Capital (ROIC) -48.44%
Return on Capital Employed (ROCE) -86.79%
Revenue Per Employee n/a
Profits Per Employee -$1.38M
Employee Count14
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.51% in the last 52 weeks. The beta is 1.07, so BioVie's price volatility has been similar to the market average.

Beta (5Y) 1.07
52-Week Price Change -84.51%
50-Day Moving Average 9.28
200-Day Moving Average 15.92
Relative Strength Index (RSI) 34.02
Average Volume (20 Days) 66,543

Short Selling Information

The latest short interest is 152,820, so 8.24% of the outstanding shares have been sold short.

Short Interest 152,820
Short Previous Month 1.21M
Short % of Shares Out 8.24%
Short % of Float 8.35%
Short Ratio (days to cover) 3.40

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -19.19M
Pretax Income -36.29M
Net Income -19.36M
EBITDA -18.96M
EBIT -19.19M
Earnings Per Share (EPS) -$16.61
Full Income Statement

Balance Sheet

The company has $23.15 million in cash and $366,430 in debt, giving a net cash position of $22.79 million or $12.29 per share.

Cash & Cash Equivalents 23.15M
Total Debt 366,430
Net Cash 22.79M
Net Cash Per Share $12.29
Equity (Book Value) 21.82M
Book Value Per Share 11.78
Working Capital 21.17M
Full Balance Sheet

Cash Flow

Operating Cash Flow -17.42M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -199.08%
Shareholder Yield -199.08%
Earnings Yield -173.18%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date Jul 7, 2025
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 2